Melacycle-3

Desogestrel 0.15mg + Ethinylestradiol 0.03mg

Melacycle-3 is a hormonal oral contraceptive tablet that consists of Desogestrel 0.15mg and Ethinylestradiol 0.03mg. This combination contains a progestogen and an oestrogen to provide an effective choice for oral contraception when used as advised by a healthcare professional.

The combination of Desogestrel and Ethinylestradiol usually works by stopping ovulation and generating hormonal conditions that make fertilization less probable to occur. Melacycle-3 should only be taken as medically advised. This is because the suitability of the combined hormone can differ depending on an individual’s medical history and other risk factors.

Composition

Each Melacycle-3 tablet consists of:

  • Desogestrel – 0.15 mg
  • Ethinylestradiol – 0.03 mg

Desogestrel is a progestogen, while ethinylestradiol is an oestrogen. Together, these hormones are used in combined oral contraceptives to help prevent pregnancy when taken correctly and consistently.

How Melacycle-3 Works?

Melacycle-3 works primarily by suppressing ovulation. The hormones in the tablet also produce changes in cervical mucus and the lining of the uterus, which contribute to its contraceptive effect.

For reliable contraceptive protection, the medicine should be taken exactly as directed by a qualified healthcare professional or according to the approved product information. The appropriate starting day, dosing schedule, missed-tablet instructions and any necessary additional contraception should be determined according to the product’s prescribing information and the individual’s circumstances.

Key Features of Melacycle-3

Melacycle-3 combines desogestrel and ethinylestradiol in a single oral tablet, providing a convenient daily formulation for women for whom a combined hormonal contraceptive is considered appropriate.

The selection of a combined contraceptive should be individualised. A healthcare professional may consider factors such as medical history, age, smoking status, blood pressure, previous contraceptive use, other medicines and individual risk factors before recommending this type of hormonal contraception.

Safety and Precautions

Like other combined hormonal contraceptives, Melacycle-3 may not be suitable for everyone. Combined hormonal contraceptives can increase the risk of blood clots, although the absolute risk is generally small. Patients should discuss their medical history with a doctor before starting treatment.

Particular care is required for individuals with a history of blood clots, certain cardiovascular conditions, migraine with aura, significant liver disease or other conditions that may make combined hormonal contraception unsuitable.

Patients should also inform their healthcare professional about prescription medicines, non-prescription medicines and supplements they are taking, as certain medicines can affect contraceptive effectiveness.

Possible adverse effects can include nausea, headache, breast tenderness, mood changes and changes in menstrual bleeding. Any persistent, severe or concerning symptoms should be discussed with a healthcare professional.

Symptoms such as sudden chest pain, difficulty breathing, severe leg pain or swelling, sudden visual changes, or unusual neurological symptoms require urgent medical attention because they may indicate a serious complication.

Use and Storage

Melacycle-3 should be used only according to professional medical advice and the approved prescribing information. Tablets should be taken consistently and at approximately the recommended time each day.

Store the medicine according to the conditions stated on the product packaging and keep it out of the reach of children.

Melacycle-3 is a prescription hormonal contraceptive and should not be started, stopped or changed without appropriate medical guidance.

Conclusion

Melacycle-3 provides a combination of Desogestrel 0.15 mg and Ethinylestradiol 0.03 mg in a convenient oral tablet formulation.

As a hormonal contraceptive, Melacycle-3 should be used consistently and only when considered appropriate by a healthcare professional. Patients should read the approved product information carefully and seek medical advice regarding contraindications, interactions, missed tablets and potential adverse effects.

packing

10×1×21 Blister

Scroll to Top